Feroldi E - Search Results

Year	Number of Results
2007	1
2008	1
2009	1
2010	3
2012	1
2013	2
2014	3
2015	2
2016	2
2017	5
2018	3
2019	3
2020	1
2024	2

1

Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children.

Chokephaibulkit K, Houillon G, Feroldi E, Bouckenooghe A. Chokephaibulkit K, et al. Among authors: feroldi e. Expert Rev Vaccines. 2016;15(2):153-66. doi: 10.1586/14760584.2016.1123097. Epub 2015 Dec 9. Expert Rev Vaccines. 2016. PMID: 26588242 Free article. Review.

2

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.

Capeding MR, Alberto ER, Bouckenooghe A, Laot TM, Chansinghakul D, Monfredo C, Machabert T, Feroldi E. Capeding MR, et al. Among authors: feroldi e. J Infect Dis. 2018 Jan 30;217(4):567-571. doi: 10.1093/infdis/jix601. J Infect Dis. 2018. PMID: 29325161 Free PMC article. Clinical Trial.

3

Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial.

Modjarrad K, Scott PT, McCauley M, Ober-Shepherd B, Sondergaard E, Amare MF, Parikh AP, Omar B, Minutello AM, Adhikarla H, Wu Y, P AR, Delore V, Mantel N, Morrison MN, Kourbanova KS, Martinez ME, Guzman I, Greenleaf ME, Darden JM, Koren MA, Hamer MJ, Lee CE, Hutter JN, Peel SA, Robb ML, Vangelisti M, Feroldi E. Modjarrad K, et al. Among authors: feroldi e. Lancet Infect Dis. 2024 Aug 14:S1473-3099(24)00406-7. doi: 10.1016/S1473-3099(24)00406-7. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39153488

4

Pathogen chip for respiratory tract infections.

Simões EA, Patel C, Sung WK, Lee CW, Loh KH, Lucero M, Nohynek H, Nai G, Thien PL, Koh CW, Chan YS, Ma J, Maurer-Stroh S, Carosone-Link P, Hibberd ML, Wong CW; ARIVAC Consortium. Simões EA, et al. J Clin Microbiol. 2013 Mar;51(3):945-53. doi: 10.1128/JCM.02317-12. Epub 2013 Jan 9. J Clin Microbiol. 2013. PMID: 23303493 Free PMC article.

5

Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.

Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, Pancharoen C, Boaz M, Bouckenooghe A, Feroldi E. Chokephaibulkit K, et al. Among authors: feroldi e. Vaccine. 2016 Nov 4;34(46):5664-5669. doi: 10.1016/j.vaccine.2016.09.018. Epub 2016 Sep 27. Vaccine. 2016. PMID: 27686833 Clinical Trial.

6

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration.

Madhi SA, López P, Zambrano B, Jordanov E, B'Chir S, Noriega F, Feroldi E. Madhi SA, et al. Among authors: feroldi e. Hum Vaccin Immunother. 2019;15(3):658-668. doi: 10.1080/21645515.2018.1546524. Epub 2019 Jan 31. Hum Vaccin Immunother. 2019. PMID: 30513252 Free PMC article.

7

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials.

Torresi J, McCarthy K, Feroldi E, Méric C. Torresi J, et al. Among authors: feroldi e. Vaccine. 2010 Nov 23;28(50):7993-8000. doi: 10.1016/j.vaccine.2010.09.035. Epub 2010 Oct 8. Vaccine. 2010. PMID: 20934459 Clinical Trial.

8

Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers.

Martinón-Torres F, Diez-Domingo J, Feroldi E, Jordanov E, B'Chir S, Da Costa X. Martinón-Torres F, et al. Among authors: feroldi e. Pediatr Infect Dis J. 2019 Mar;38(3):317-322. doi: 10.1097/INF.0000000000002231. Pediatr Infect Dis J. 2019. PMID: 30408001 Clinical Trial.

9

Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.

Vien NC, Feroldi E, Lang J. Vien NC, et al. Among authors: feroldi e. Trans R Soc Trop Med Hyg. 2008 Mar;102(3):294-6. doi: 10.1016/j.trstmh.2007.11.010. Epub 2008 Jan 14. Trans R Soc Trop Med Hyg. 2008. PMID: 18191971

10

Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic.

Prymula R, Kieninger D, Feroldi E, Jordanov E, B'Chir S, DaCosta X. Prymula R, et al. Among authors: feroldi e. Pediatr Infect Dis J. 2018 Aug;37(8):823-830. doi: 10.1097/INF.0000000000002109. Pediatr Infect Dis J. 2018. PMID: 29762363 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year